BioSpace News Archive

As drugmakers continue to develop an understanding of what pain is to the human body, it helps drive the development of innovative manners to treat it that transcend addictive options such as opioids.

Medtronic plc today announced the pricing terms of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc., the “Offerors”), for any and all (the “Any and All Tender Offers”) of the $3.1 billion in aggregate principal amount of the outstanding Notes

Annual General Meeting to take place on 18 April 2019 in Basel

Gyroscope Therapeutics has dosed its first patient in Phase I/II study in dry AMD

Apogenix announced today that it will present an overview of its HERA-ligand technology platform for cancer immunotherapy at Cambridge Healthtech Institute’s 4thAnnual Cancer Immunotherapy: Executive Summit

The University of Manchester, and Owlstone Medical announce the award of an Asthma UK/Innovate UK grant for theimprovement of asthma diagnosis.

Experts from Peli BioThermal to share knowledge and industry insight at leading clinical trial conference

Evotec AG announced that its management will be presenting at and attending the following upcoming conferences:

Prospective drug found by testing in human heart muscle grown from stem cells

Akili receives upfront payments totalling $20 million and has the potential to receive milestone payments for Japan and Taiwan commercialisation of up to an additional $105 million, in addition to substantial royalties on product sales